ARS Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ARS Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2021 to Q3 2024.
  • ARS Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 6, 2024 was 97.2M shares, a 1.24% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 97.2M +1.19M +1.24% Nov 6, 2024 10-Q/A 2024-12-06
Q2 2024 96.9M +1.37M +1.44% Aug 2, 2024 10-Q 2024-08-06
Q1 2024 96.5M +2.1M +2.22% Mar 18, 2024 10-K 2024-03-21
Q3 2023 96M +59.9M +166% Nov 6, 2023 10-Q 2023-11-09
Q2 2023 95.6M +60.1M +169% Aug 7, 2023 10-Q 2023-08-10
Q1 2023 94.4M +59.3M +169% Mar 17, 2023 10-K 2023-03-23
Q3 2022 36.1M +982K +2.8% Oct 31, 2022 10-Q 2022-11-02
Q2 2022 35.5M +437K +1.25% Aug 8, 2022 10-Q 2022-08-11
Q1 2022 35.1M +238K +0.68% Mar 28, 2022 10-K 2022-03-31
Q3 2021 35.1M Nov 8, 2021 10-Q 2021-11-10
Q2 2021 35M Aug 10, 2021 10-Q 2021-08-12
Q1 2021 34.9M May 10, 2021 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.